Nutrien Gets Price Target Cuts By Analysts After Downbeat Q1 Results

Nutrien Ltd. (NYSE: NTR) reported worse-than-expected Q1 financial results and issued FY23 adjusted EPS guidance below estimates.

Nutrien Ltd. (NYSE:NTR) reported worse-than-expected Q1 financial results and issued FY23 adjusted EPS guidance below estimates.

Nutrien posted adjusted earnings of $1.11 per share, missing analysts’ estimates of $1.49 per share. The company’s quarterly sales came in at $6.11 billion, missing expectations of $6.43 billion.

Nutrien said it sees FY23 adjusted earnings of $5.50 to $7.50 per share, versus analysts’ estimates of $8.63 per share.

Nutrien shares fell 4.1% to trade at $59.19 on Friday.

These analysts made changes to their price targets on Nutrien following earnings announcement.

  • Barclays cut the price target on Nutrien from $93 to $80. Barclays analyst Benjamin Theurer maintained an Overweight rating.
  • Mizuho lowered the price target on Nutrien from $79 to $75. Mizuho analyst Christopher Parkinson maintained a Neutral rating
  • RBC Capital cut Nutrien price target from $100 to $95. RBC Capital analyst Andrew Quail maintained the stock with an Outperform.
  • Credit Suisse, on Thursday, slashed Nutrien price target from $70 to $60. Credit Suisse analyst Edlain Rodriguez reiterated the stock with an Underperform.

 

Check This Out: Top 5 Industrials Stocks That May Explode In Q2

Total
0
Shares
Related Posts
Read More

Recap: Curtiss-Wright Q2 Earnings

Curtiss-Wright (NYSE:CW) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Curtiss-Wright beat estimated earnings by 8.28%, reporting an EPS of $1.83 versus an estimate of $1.69.

CW